Larimar Therapeutics (LRMR) Stock Price, Quote, News & History

Comments

Larimar Therapeutics Inc (LRMR) Stock Price, Quote, News & History

LRMRNASDAQ

Trade with Public

$5.62

-0.33-5.55%

Last update: Feb 26, 11:43 AM

Why is it moving?: Laminar Therapeutics Stock Is Popping Today: What's Going On?

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$5.38

Close

-

Volume / Avg.

7.10M / 3.61M

Day Range

$5.20 - $5.67

52 Wk Range

1.61 - 6.42

Market Cap

$466.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

16.49%

Days to Cover

10.63

Recent Larimar Therapeutics Inc News

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Laminar Therapeutics Stock Is Popping Today: What's Going On?

Larimar Therapeutics Inc (NASDAQ:LRMR) shares are soaring on Wednesday after multiple analysts reiterated their bullish outlook.

Evette Mitkov

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-96.49M

Investing Cash Flow (TTM)

85.51M

Financing Cash Flow (TTM)

65.32M

Free Cash Flow (TTM)

-96.76M

Capital Expenditure (TTM)

-270.00K

Net Change in Cash (TTM)

54.34M

Analyst Trends and Forecast

2

Sep 25

1

Oct 25

2

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$323.30M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.56

Earnings Yield % (TTM)

-32.94%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.67

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$90.14M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.38

Close

-

Volume / Avg.

7.10M / 3.61M

Day Range

$5.20 - $5.67

52 Wk Range

1.61 - 6.42

Market Cap

$466.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

16.49%

Days to Cover

10.63

About

Sector

Health Care

Industry

Biotechnology

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Larimar Therapeutics (LRMR) stock?

A

You can purchase shares of Larimar Therapeutics (NASDAQ:LRMR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Larimar Therapeutics (LRMR) competitors?

A

Other companies in Larimar Therapeutics’s space includes: Zura Bio Ltd (NASDAQ:ZURA), 4D Molecular Therapeutics Inc (NASDAQ:FDMT), Altimmune Inc (NASDAQ:ALT), ADC Therapeutics SA (NYSE:ADCT) and Prothena Corp PLC (NASDAQ:PRTA).

Q

What is the forecast, or price target, for Larimar Therapeutics (LRMR) stock?

A

Larimar Therapeutics has a consensus price target of $17.00.

Q

What is the current price for Larimar Therapeutics (LRMR)?

A

The stock price for Larimar Therapeutics (NASDAQ: LRMR) is $5.62 last updated February 26, 2026 at 11:43 AM EST.

Q

Does Larimar Therapeutics (LRMR) pay a dividend?

A

There are no upcoming dividends for Larimar Therapeutics.

Q

When is Larimar Therapeutics (NASDAQ:LRMR) reporting earnings?

A

Larimar Therapeutics does not have any upcoming earnings scheduled.

Q

Is Larimar Therapeutics (LRMR) going to split?

A

There is no upcoming split for Larimar Therapeutics.

Q

What sector and industry does Larimar Therapeutics (LRMR) operate in?

A

Larimar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

4D Molecular Therapeutics Inc

Kyverna Therapeutics Inc

NASDAQ:KYTX

$8.02

-0.93%

Ironwood Pharmaceuticals Inc

NASDAQ:IRWD

$3.60

6.99%

Key Statistics

Open

$5.38

Close

-

Volume / Avg.

7.10M / 3.61M

Day Range

$5.20 - $5.67

52 Wk Range

1.61 - 6.42

Market Cap

$466.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

16.49%

Days to Cover

10.63

Recent Larimar Therapeutics Inc News

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Laminar Therapeutics Stock Is Popping Today: What's Going On?

Larimar Therapeutics Inc (NASDAQ:LRMR) shares are soaring on Wednesday after multiple analysts reiterated their bullish outlook.

Evette Mitkov

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-96.49M

Investing Cash Flow (TTM)

85.51M

Financing Cash Flow (TTM)

65.32M

Free Cash Flow (TTM)

-96.76M

Capital Expenditure (TTM)

-270.00K

Net Change in Cash (TTM)

54.34M

Analyst Trends and Forecast

2

Sep 25

1

Oct 25

2

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$323.30M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.56

Earnings Yield % (TTM)

-32.94%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.67

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$90.14M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.38

Close

-

Volume / Avg.

7.10M / 3.61M

Day Range

$5.20 - $5.67

52 Wk Range

1.61 - 6.42

Market Cap

$466.97M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

76

Short Interest

16.49%

Days to Cover

10.63

About

Sector

Health Care

Industry

Biotechnology

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry